Together, our results show that both AXIN1-mutant and CTNNB1-mutant HCC display elevated Wnt/β-catenin signaling, although levels of pathway activation are more moderate for AXIN1-mutant cells. The gene discussed is CTNNB1; the disease is hepatocellular carcinoma.